Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.536 Q1 | 70 | 6 | 43 | 1620 | 277 | 43 | 5.84 | 270.00 | |
2 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
3 | Progress in Medicinal Chemistry | journal | 1.288 Q1 | 38 | 8 | 19 | 1459 | 55 | 6 | 3.31 | 182.38 | |
4 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
5 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
6 | Cellular and Molecular Life Sciences | journal | 2.575 Q1 | 261 | 183 | 547 | 16769 | 2344 | 533 | 4.40 | 91.63 | |
7 | Current Drug Metabolism | journal | 0.329 Q2 | 122 | 28 | 20 | 2547 | 16 | 20 | 0.80 | 90.96 | |
8 | Expert Opinion on Biological Therapy | journal | 102 | 84 | 0 | 6963 | 0 | 0 | 0.00 | 82.89 | ||
9 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 39 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
10 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 12 | 17 | 0 | 1305 | 0 | 0 | 0.00 | 76.76 | ||
11 | Drug Safety | journal | 1.019 Q1 | 140 | 86 | 238 | 6344 | 955 | 231 | 3.96 | 73.77 | |
12 | Apoptosis : an international journal on programmed cell death | journal | 0.446 Q2 | 128 | 47 | 159 | 3353 | 143 | 159 | 0.89 | 71.34 | |
13 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
14 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
15 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 51 | 153 | 3328 | 6 | 153 | 0.06 | 65.25 | |
16 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 117 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
17 | Clinical Pharmacokinetics | journal | 1.435 Q1 | 184 | 75 | 206 | 4310 | 1107 | 198 | 5.14 | 57.47 | |
18 | Expert Opinion on Therapeutic Patents | journal | 0.404 Q2 | 88 | 126 | 429 | 6674 | 437 | 424 | 1.02 | 52.97 | |
19 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
20 | Pharmacogenomics | journal | 0.616 Q2 | 100 | 40 | 35 | 2061 | 66 | 35 | 1.89 | 51.53 | |
21 | Antiviral Therapy | journal | 0.924 Q1 | 93 | 41 | 164 | 2087 | 329 | 147 | 2.12 | 50.90 | |
22 | Journal of International Peacekeeping | journal | 14 | 25 | 76 | 1264 | 0 | 64 | 0.00 | 50.56 | ||
23 | Neuropsychopharmacology | journal | 2.239 Q1 | 249 | 182 | 427 | 9179 | 2111 | 397 | 4.68 | 50.43 | |
24 | International Journal of Neuropsychopharmacology | journal | 0.490 Q2 | 125 | 50 | 113 | 2485 | 150 | 110 | 1.34 | 49.70 | |
25 | Current Opinion in Pharmacology | journal | 148 | 92 | 0 | 4567 | 0 | 0 | 0.00 | 49.64 | ||
26 | Drugs of the Future | journal | 0.363 Q2 | 46 | 84 | 315 | 4137 | 311 | 315 | 1.09 | 49.25 | |
27 | International Immunopharmacology | journal | 149 | 199 | 611 | 9446 | 1035 | 597 | 1.73 | 47.47 | ||
28 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q3 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 | |
29 | Molecular Diagnosis and Therapy | journal | 68 | 77 | 145 | 3529 | 243 | 122 | 1.89 | 45.83 | ||
30 | Current Opinion in Drug Discovery and Development | journal | 0.561 Q2 | 85 | 82 | 160 | 3724 | 306 | 152 | 1.83 | 45.41 | |
31 | Drug News and Perspectives | journal | 0.260 Q3 | 53 | 60 | 174 | 2697 | 107 | 174 | 0.50 | 44.95 | |
32 | Psychopharmacology | journal | 1.420 Q1 | 214 | 336 | 1010 | 14966 | 3371 | 987 | 3.29 | 44.54 | |
33 | PharmacoEconomics | journal | 0.732 Q1 | 118 | 108 | 400 | 4797 | 854 | 377 | 2.14 | 44.42 | |
34 | Current Opinion in Molecular Therapeutics | journal | 0.405 Q2 | 67 | 82 | 183 | 3634 | 214 | 170 | 1.17 | 44.32 | |
35 | Antiviral Research | journal | 0.725 Q1 | 151 | 68 | 195 | 2952 | 498 | 195 | 2.12 | 43.41 | |
36 | Receptors and Channels | journal | 0.944 Q1 | 44 | 21 | 71 | 906 | 121 | 71 | 1.28 | 43.14 | |
37 | Environmental Toxicology and Pharmacology | journal | 0.526 Q2 | 106 | 42 | 131 | 1727 | 146 | 130 | 1.21 | 41.12 | |
38 | BMC Pharmacology | journal | 48 | 13 | 0 | 532 | 0 | 0 | 0.00 | 40.92 | ||
39 | Antiviral Chemistry and Chemotherapy | journal | 0.547 Q2 | 59 | 37 | 121 | 1504 | 220 | 121 | 1.91 | 40.65 | |
40 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.102 Q4 | 5 | 8 | 67 | 320 | 13 | 65 | 0.05 | 40.00 | |
41 | Neuropharmacology | journal | 1.900 Q1 | 191 | 229 | 631 | 9109 | 2510 | 629 | 3.97 | 39.78 | |
42 | European Neuropsychopharmacology | journal | 0.640 Q2 | 130 | 72 | 236 | 2827 | 446 | 215 | 1.86 | 39.26 | |
43 | Saudi Pharmaceutical Journal | journal | 0.145 Q4 | 76 | 27 | 84 | 1055 | 12 | 77 | 0.17 | 39.07 | |
44 | Drugs of Today | journal | 0.215 Q3 | 57 | 113 | 337 | 4381 | 197 | 333 | 0.61 | 38.77 | |
45 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.111 Q4 | 5 | 5 | 35 | 191 | 2 | 35 | 0.09 | 38.20 | |
46 | Drug and Alcohol Dependence | journal | 1.123 Q1 | 187 | 135 | 348 | 5104 | 1019 | 335 | 2.54 | 37.81 | |
47 | Xenobiotica | journal | 0.557 Q2 | 89 | 63 | 275 | 2378 | 561 | 274 | 1.95 | 37.75 | |
48 | International Journal of Immunopathology and Pharmacology | journal | 0.191 Q3 | 65 | 23 | 70 | 857 | 36 | 69 | 0.68 | 37.26 | |
49 | Inflammopharmacology | journal | 0.190 Q3 | 68 | 30 | 89 | 1117 | 44 | 89 | 0.50 | 37.23 | |
50 | Journal of Psychopharmacology | journal | 0.978 Q1 | 135 | 51 | 223 | 1870 | 580 | 196 | 2.05 | 36.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®